Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Tianjin Chase Sun Pharmaceutical (300026)
- 3.35
- -0.02-0.59%
Market Closed Apr 24 15:00 CST
10.06BMarket Cap558.33P/E (TTM)
3.37High3.33Low254.68KlotVolume3.36Open3.37Prev Close85.32MTurnover0.85%Turnover Ratio558.33P/E (Static)3.00BShares4.4952wk High1.18P/B10.05BFloat Cap3.2252wk Low4.04Limit Up3.00BShs Float10.63Historical High2.70Limit Down1.19%Range %1.13Historical Low0.03Dividend TTM3.35Avg Price132.55KlotAsk0.90%Div Yield TTM100Lot Size121.14KlotBid
Tianjin Chase Sun Pharmaceutical (300026) Income Statement
All
YOY
| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -14.55%4.94B | -6.59%4.15B | -6.72%2.79B | -4.82%1.39B | -5.34%5.78B | -9.78%4.44B | -12.48%3B | -11.80%1.46B | -8.14%6.11B | 0.45%4.92B |
| Operating revenue | -14.55%4.94B | -6.59%4.15B | -6.72%2.79B | -4.82%1.39B | -5.34%5.78B | -9.78%4.44B | -12.48%3B | -11.80%1.46B | -8.14%6.11B | 0.45%4.92B |
| Other operating revenue | 24.73%32.73M | ---- | 156.95%18.57M | ---- | -68.88%26.24M | ---- | -63.44%7.23M | ---- | 77.73%84.31M | ---- |
| Total operating cost | -17.23%4.63B | -6.99%3.91B | -5.03%2.66B | -4.21%1.31B | 0.02%5.59B | -4.19%4.2B | -7.79%2.8B | -7.48%1.37B | -5.57%5.59B | 0.03%4.39B |
| Operating cost | -24.59%2.06B | -6.56%1.98B | -3.75%1.36B | -6.04%670.11M | -2.55%2.73B | -3.47%2.12B | -3.93%1.41B | 0.15%713.22M | -0.28%2.8B | 0.05%2.2B |
| Operating tax surcharges | 1.93%64.07M | 2.13%46.51M | -0.80%32.58M | 9.88%17.08M | 8.67%62.86M | 3.76%45.54M | 11.01%32.84M | 24.45%15.55M | -6.27%57.84M | 6.40%43.89M |
| Operating expense | -11.17%1.88B | -7.35%1.43B | -7.46%966.62M | -2.08%468.64M | 4.52%2.12B | -4.68%1.55B | -12.84%1.04B | -16.80%478.57M | -12.58%2.03B | -0.44%1.62B |
| Administration expense | -3.28%405.54M | -0.73%303.29M | 2.02%208.29M | -2.63%102.31M | -4.32%419.29M | -7.54%305.52M | -6.27%204.16M | -4.81%105.08M | 0.68%438.24M | 6.90%330.43M |
| Financial expense | -40.96%16.14M | -64.26%10.05M | -68.29%6.18M | -61.79%3.96M | -40.18%27.34M | -22.73%28.13M | -27.70%19.5M | -40.64%10.35M | -14.61%45.71M | 18.38%36.41M |
| -Interest expense (Financial expense) | -56.90%19.33M | -64.02%14.43M | -64.87%10.04M | -67.20%4.99M | -27.14%44.86M | -13.27%40.12M | -14.89%28.58M | -10.92%15.21M | -11.62%61.57M | -6.03%46.26M |
| -Interest Income (Financial expense) | 37.35%-10.84M | 40.27%-8.2M | 45.45%-5.24M | 66.00%-1.88M | 10.38%-17.31M | -11.87%-13.73M | -21.16%-9.61M | -53.17%-5.54M | -75.18%-19.31M | -37.89%-12.27M |
| Research and development | -13.48%197.74M | -13.87%132.73M | -0.83%92.91M | 7.04%47.48M | 6.01%228.54M | 0.02%154.1M | -7.41%93.69M | -11.24%44.36M | -8.91%215.59M | -12.51%154.07M |
| Credit Impairment Loss | 26.98%-72.31M | 9.33%-45.77M | 82.64%-6.59M | 54.90%-11.29M | -51.21%-99.03M | -74.93%-50.47M | -1,572.18%-37.95M | -310.01%-25.03M | 17.53%-65.49M | -20.47%-28.85M |
| Asset Impairment Loss | -75.19%-166.22M | -308.60%-48.13M | -380.52%-30.5M | -63.39%-3.71M | -152.12%-94.88M | -100.81%-11.78M | -11.65%-6.35M | 17.11%-2.27M | -684.44%-37.63M | -89.29%-5.87M |
| Other net revenue | -33.55%-210.82M | -102.33%-75.04M | 11.25%-24.23M | 75.96%-4.86M | -408.68%-157.86M | -636.41%-37.09M | -291.36%-27.3M | -220.83%-20.24M | -59.36%-31.03M | -74.27%6.91M |
| Invest income | 35.01%-3.66M | -160.99%-2.87M | -96.27%-2.42M | 35.98%-157.07K | -301.83%-5.63M | -132.33%-1.1M | -46.70%-1.23M | 52.80%-245.33K | -144.35%-1.4M | -141.60%-474.06K |
| -Including: Investment income associates | -203.66%-3.66M | -154.69%-2.8M | -90.49%-2.35M | 35.98%-157.07K | -359.45%-1.21M | -138.81%-1.1M | -46.70%-1.23M | 52.80%-245.33K | -76.39%464.52K | -140.45%-461.06K |
| Asset deal income | -34.91%702.54K | 245.55%93.11K | -100.33%-1.89K | -188.73%-2.78K | 1.57%1.08M | 78.18%-63.97K | 1,192.64%574.69K | 107.45%3.13K | 20,693.52%1.06M | -60.12%-293.25K |
| Other revenue | -24.48%30.66M | -17.81%21.64M | -13.45%15.28M | 40.91%10.29M | -43.95%40.6M | -37.90%26.33M | -23.61%17.66M | -10.16%7.3M | 17.64%72.43M | -19.94%42.4M |
| Operating profit | 193.81%104.12M | -18.32%164.28M | -34.78%107.16M | 3.06%78.33M | -92.76%35.44M | -62.94%201.13M | -58.54%164.31M | -61.64%76M | -31.33%489.27M | 0.14%542.78M |
| Add:Non operating Income | -68.32%13.56M | -19.15%9.91M | -51.69%5.18M | 3.88%1.25M | -65.97%42.82M | -78.58%12.26M | -35.24%10.72M | -92.57%1.2M | 203.47%125.81M | 65.22%57.21M |
| Less:Non operating expense | 44.36%35.04M | 187.64%32.99M | -41.00%3.03M | 901.85%2.7M | 194.03%24.27M | 92.51%11.47M | 8.49%5.13M | 18.94%269.47K | -78.05%8.25M | 11.08%5.96M |
| Total profit | 53.09%82.65M | -30.07%141.2M | -35.66%109.31M | -0.07%76.88M | -91.10%53.98M | -66.01%201.92M | -58.37%169.9M | -64.07%76.93M | -15.29%606.82M | 3.98%594.03M |
| Less:Income tax cost | 94.67%60.42M | 417.63%49.27M | 42.85%24.69M | -33.47%14.99M | -70.51%31.04M | -88.40%9.52M | -70.41%17.28M | -36.21%22.54M | 10.64%105.25M | -19.34%82.07M |
| Net profit | -3.15%22.22M | -52.22%91.93M | -44.55%84.62M | 13.76%61.88M | -95.43%22.95M | -62.42%192.4M | -56.36%152.61M | -69.57%54.4M | -19.26%501.57M | 9.04%511.96M |
| Net profit from continuing operation | -3.15%22.22M | -52.22%91.93M | -44.55%84.62M | 13.76%61.88M | -95.43%22.95M | -62.42%192.4M | -56.36%152.61M | -69.57%54.4M | -19.26%501.57M | 9.04%511.96M |
| Less:Minority Profit | 152.10%3.73M | -53.56%11.17M | 36.78%5.99M | 141.77%1.55M | 129.21%1.48M | 764.14%24.04M | 13.57%4.38M | -211.50%-3.72M | -68.36%-5.06M | 412.84%2.78M |
| Net profit of parent company owners | -13.85%18.5M | -52.03%80.76M | -46.95%78.63M | 3.80%60.33M | -95.76%21.47M | -66.94%168.36M | -57.14%148.23M | -66.87%58.12M | -18.84%506.63M | 8.24%509.18M |
| Earning per share | ||||||||||
| Basic earning per share | 0.00%0.01 | -50.00%0.03 | -40.00%0.03 | 0.00%0.02 | -94.12%0.01 | -64.71%0.06 | -58.33%0.05 | -66.67%0.02 | -19.05%0.17 | 6.25%0.17 |
| Diluted earning per share | 0.00%0.01 | -50.00%0.03 | -40.00%0.03 | 0.00%0.02 | -94.12%0.01 | -64.71%0.06 | -58.33%0.05 | -66.67%0.02 | -19.05%0.17 | 6.25%0.17 |
| Other composite income | -2,775.77%-55.63M | 79.53%-308.94K | -75.38%202.26K | 129.87%126.1K | -46.62%2.08M | -127.75%-1.51M | -88.74%821.47K | 86.39%-422.15K | -70.88%3.89M | -73.28%5.44M |
| Other composite income of parent company owners | -2,775.77%-55.63M | 79.53%-308.94K | -75.38%202.26K | 129.87%126.1K | -46.62%2.08M | -127.75%-1.51M | -88.74%821.47K | 86.39%-422.15K | -70.88%3.89M | -73.28%5.44M |
| Total composite income | -233.48%-33.4M | -52.00%91.62M | -44.72%84.83M | 14.89%62.01M | -95.05%25.03M | -63.11%190.89M | -57.02%153.44M | -69.28%53.98M | -20.35%505.46M | 5.62%517.4M |
| Total composite income of parent company owners | -257.69%-37.13M | -51.78%80.45M | -47.11%78.83M | 4.78%60.46M | -95.39%23.55M | -67.58%166.85M | -57.80%149.05M | -66.52%57.7M | -19.93%510.53M | 4.86%514.62M |
| Total composite income of minority owners | 152.10%3.73M | -53.56%11.17M | 36.78%5.99M | 141.77%1.55M | 129.21%1.48M | 764.14%24.04M | 13.57%4.38M | -211.50%-3.72M | -68.36%-5.06M | 412.84%2.78M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | ShinWing Certified Public Accountants (Special General Partnership) | -- | -- | -- | ShinWing Certified Public Accountants (Special General Partnership) | -- | -- | -- | ShinWing Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm